Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_assertion type Assertion NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_head.
- NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_assertion description "[We systematically analyzed the expression of vascular endothelial growth factor A (VEGFA), fibroblast growth factor 2 (FGF2), thrombospondin 1 (THBS1), and brain-specific angiogenesis inhibitor 1 (BAI1), and we correlated the results with microvessel count (MVC), MSI status, p53 mutations, and prostaglandin-endoperoxide synthase 2 (PTGS2) expression in gastric cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_provenance.
- NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_assertion evidence source_evidence_literature NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_provenance.
- NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_assertion SIO_000772 17374440 NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_provenance.
- NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_assertion wasDerivedFrom befree-2016 NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_provenance.
- NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_assertion wasGeneratedBy ECO_0000203 NP600094.RAF09iXq-y5SsycIQA4r-_ioXWHjJ1O5c_Ny3COET8PsI130_provenance.